Chengdu Olymvax Biopharmaceuticals Inc.

SHSE:688319 Lagerbericht

Marktkapitalisierung: CN¥4.2b

Chengdu Olymvax Biopharmaceuticals Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Shaowen Fan

Geschäftsführender

CN¥713.5k

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer14.8yrs
Eigentum des Geschäftsführers3.9%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder8.4yrs

Jüngste Management Updates

Recent updates

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Oct 09
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

Sep 30
We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Jun 24
What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

May 28
Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Apr 18
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

Mar 26
These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

Geschäftsführer

Shaowen Fan (71 yo)

14.8yrs

Amtszeit

CN¥713,500

Vergütung

Mr. Shaowen Fan is Chairman of the Board & GM of Chengdu Olymvax Biopharmaceuticals Inc. from January 2010. Mr. Fan joined the Chengdu Olymvax Biopharmaceuticals Inc. in 2010.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Shaowen Fan
Chairman of the Board & GM14.8yrsCN¥713.50k3.86%
CN¥ 161.1m
Yunhui Yu
Director11.4yrsCN¥42.00k0.014%
CN¥ 575.9k
Pengfei Zhang
Chairman of Supervisory Board8.4yrskeine Daten6.38%
CN¥ 266.2m
Fan Fan
Executive Deputy GM & Vice Chairman of the Board14.8yrsCN¥633.20k7.53%
CN¥ 314.3m
Cheng Hu
Director2.5yrsCN¥42.00k1.64%
CN¥ 68.5m
Aimin Chen
Director14.8yrsCN¥602.00k0.15%
CN¥ 6.3m
Lu Lu
Employee Representative Director2.5yrsCN¥195.00k0.067%
CN¥ 2.8m
Shao Ping He
Independent Director5.6yrsCN¥83.90kkeine Daten
Hua Yan
Supervisor2.5yrskeine Daten0.20%
CN¥ 8.4m

8.4yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: 688319Die Vorstandsmitglieder gelten als erfahren (8.4 Jahre durchschnittliche Amtszeit).